Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01FDW
|
||||
Former ID |
DNC007624
|
||||
Drug Name |
ARGENINE VASOPRESSIN
|
||||
Indication | Discovery agent | Investigative | [528674] | ||
Structure |
Download2D MOL |
||||
Formula |
C46H65N15O12S2
|
||||
Canonical SMILES |
C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(<br />C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N<br />)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
|
||||
InChI |
1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28+,29-,30-,31+,32+,33+,34-/m1/s1
|
||||
InChIKey |
KBZOIRJILGZLEJ-BOXDWKHASA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vasopressin V2 receptor | Target Info | Inhibitor | [528674] | |
Vasopressin V1b receptor | Target Info | Inhibitor | [528674] | ||
Oxytocin receptor | Target Info | Inhibitor | [528674] | ||
Vasopressin V1a receptor | Target Info | Inhibitor | [528674] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Vasopressin-regulated water reabsorptionhsa04020:Calcium signaling pathway | |||||
Vascular smooth muscle contractionhsa04020:Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Oxytocin signaling pathwayhsa04020:Calcium signaling pathway | |||||
Vascular smooth muscle contraction | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
PANTHER Pathway | Oxytocin receptor mediated signaling pathway | ||||
Pathway Interaction Database | Arf6 trafficking events | ||||
PathWhiz Pathway | Vasopressin Regulation of Water Homeostasis | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Regulation of Water Balance by Renal Aquaporins | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Myometrial Relaxation and Contraction Pathways | |||||
Oxytocin signaling | |||||
GPCR downstream signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.